Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

X4 Pharmaceuticals (XFOR) Asset Utilization Ratio (2018 - 2025)

X4 Pharmaceuticals' Asset Utilization Ratio history spans 7 years, with the latest figure at 0.15 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 881.82% year-over-year to 0.15; the TTM value through Dec 2025 reached 0.15, up 881.82%, while the annual FY2025 figure was 0.16, 823.12% up from the prior year.
  • Asset Utilization Ratio reached 0.15 in Q4 2025 per XFOR's latest filing, down from 0.25 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.28 in Q2 2025 to a low of 0.03 in Q1 2023.
  • Average Asset Utilization Ratio over 4 years is 0.05, with a median of 0.01 recorded in 2023.
  • Peak YoY movement for Asset Utilization Ratio: tumbled 255.27% in 2023, then skyrocketed 7889.93% in 2025.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.03 in 2022, then surged by 76.69% to 0.01 in 2023, then soared by 327.68% to 0.02 in 2024, then skyrocketed by 881.82% to 0.15 in 2025.
  • Per Business Quant, the three most recent readings for XFOR's Asset Utilization Ratio are 0.15 (Q4 2025), 0.25 (Q3 2025), and 0.28 (Q2 2025).